The FDA has found N-nitrosodimethylamine (NDMA) levels, in some Ranitidine products, may increase to unacceptable levels posing a risk to consumers. As such, NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory test

As a result, on April 1, 2020, the FDA has requested a manufacturer’s market withdrawal of all Ranitidine and OTC Ranitidine products (Zantac) and recommends consumers dispose of any Ranitidine products and discontinue any future purchases including compounded Ranitidine (Zantac).

Studies have linked NDMA, the potential contaminant in Zantac to:

• Bladder Cancer

• Colorectal Cancer

• Esophageal Cancer

• Intestinal Cancer

• Kidney Cancer

• Liver Cancer

• Ovarian Cancer

• Pancreatic Cancer

• Stomach Cancer

• Testicular Cancer

• Uterine Cancer

WHEN FIGHTING FOR OUR CLIENTS, OUR LAW FIRM ROUTINELY STANDS UP TO SOME OF THE WORLD’S MOST POWERFUL INDUSTRIES.

Our firm is a leader in handling mass torts – lawsuits involving many clients who have been harmed by the same defective product, dangerous drug or wrongful actions of a common corporation or organization. Our attorneys are respected, dedicated, and experienced. Every personal injury lawyer at Davis & Crump understands the significance of your claim.

If you have taken Zantac or Ranitidine, and have developed cancer, Davis & Crump is ready to help you. You may be eligible for compensation for medical bills, lost wages, permanent or temporary disability, or pain and suffering.

Contact our experienced attorneys by filling out a Free Claim Evaluation https://www.daviscrump.com/free-claim-evaluation/, call us toll free 1-800-277-0300, or email us info@daviscrump.com to get started.